Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration. 2017

Jessica L Cohen-Pfeffer, and Sridharan Gururangan, and Thomas Lester, and Daniel A Lim, and Adam J Shaywitz, and Manfred Westphal, and Irene Slavc
BioMarin Pharmaceutical Inc, Novato, California.

Intrathecal delivery methods have been used for many decades to treat a broad range of central nervous system disorders. A literature review demonstrated that intracerebroventricular route is an established and well-tolerated method for prolonged central nervous system drug delivery in pediatric and adult populations. Intracerebroventricular devices were present in patients from one to 7156 days. The number of punctures per device ranged from 2 to 280. Noninfectious complication rates per patient (range, 1.0% to 33.0%) were similar to infectious complication rates (0.0% to 27.0%). Clinician experience and training and the use of strict aseptic techniques have been shown to reduce the frequency of complications.

UI MeSH Term Description Entries
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D002491 Central Nervous System Agents A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252) Central Nervous System Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug

Related Publications

Jessica L Cohen-Pfeffer, and Sridharan Gururangan, and Thomas Lester, and Daniel A Lim, and Adam J Shaywitz, and Manfred Westphal, and Irene Slavc
September 2017, Translational and clinical pharmacology,
Jessica L Cohen-Pfeffer, and Sridharan Gururangan, and Thomas Lester, and Daniel A Lim, and Adam J Shaywitz, and Manfred Westphal, and Irene Slavc
December 1981, Journal of pharmaceutical sciences,
Jessica L Cohen-Pfeffer, and Sridharan Gururangan, and Thomas Lester, and Daniel A Lim, and Adam J Shaywitz, and Manfred Westphal, and Irene Slavc
November 1985, Pharmacology, biochemistry, and behavior,
Jessica L Cohen-Pfeffer, and Sridharan Gururangan, and Thomas Lester, and Daniel A Lim, and Adam J Shaywitz, and Manfred Westphal, and Irene Slavc
February 2016, Clinical pharmacokinetics,
Jessica L Cohen-Pfeffer, and Sridharan Gururangan, and Thomas Lester, and Daniel A Lim, and Adam J Shaywitz, and Manfred Westphal, and Irene Slavc
June 1993, Pharmaceutical research,
Jessica L Cohen-Pfeffer, and Sridharan Gururangan, and Thomas Lester, and Daniel A Lim, and Adam J Shaywitz, and Manfred Westphal, and Irene Slavc
March 2005, Journal of controlled release : official journal of the Controlled Release Society,
Jessica L Cohen-Pfeffer, and Sridharan Gururangan, and Thomas Lester, and Daniel A Lim, and Adam J Shaywitz, and Manfred Westphal, and Irene Slavc
April 2013, International urogynecology journal,
Jessica L Cohen-Pfeffer, and Sridharan Gururangan, and Thomas Lester, and Daniel A Lim, and Adam J Shaywitz, and Manfred Westphal, and Irene Slavc
October 2018, Brain research bulletin,
Jessica L Cohen-Pfeffer, and Sridharan Gururangan, and Thomas Lester, and Daniel A Lim, and Adam J Shaywitz, and Manfred Westphal, and Irene Slavc
May 2024, Drug discovery today,
Jessica L Cohen-Pfeffer, and Sridharan Gururangan, and Thomas Lester, and Daniel A Lim, and Adam J Shaywitz, and Manfred Westphal, and Irene Slavc
January 2024, Frontiers in chemistry,
Copied contents to your clipboard!